Stephens Inc Moderna, Inc. Transaction History

Stephens Inc

$6.31 Billion
Q2 2024

A detailed history of Stephens Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Stephens Inc holds 3,089 shares of MRNA stock, worth $210,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,089

Previous 3,483 11.31%

Holding current value

$210,916

Previous $371,000 1.35%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$101.21 - $166.61 $39,876 - $65,644	-394 Reduced 11.31%	3,089 $366,000
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $13,232 - $17,893	155 Added 4.66%	3,483 $371,000
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $14,458 - $21,721	-208 Reduced 5.88%	3,328 $330,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $1,928 - $2,532	-20 Reduced 0.56%	3,536 $365,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $11,850 - $16,053	-100 Reduced 2.74%	3,556 $432,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $5,426 - $7,880	40 Added 1.11%	3,656 $561,000
Q4 2022 Jan 25, 2023	BUY	$118.38 - $210.04 $34,330 - $60,911	290 Added 8.72%	3,616 $650,000
Q3 2022 Nov 02, 2022	BUY	$118.07 - $194.18 $11,570 - $19,029	98 Added 3.04%	3,326 $393,000
Q2 2022 Aug 03, 2022	BUY	$117.13 - $176.59 $13,352 - $20,131	114 Added 3.66%	3,228 $461,000
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $24,406 - $45,364	193 Added 6.61%	3,114 $536,000
Q4 2021 Mar 07, 2022	BUY	$225.82 - $368.51 $56,455 - $92,127	250 Added 9.36%	2,921 $742,000
Q3 2021 Oct 27, 2021	SELL	$221.9 - $484.47 $15,533 - $33,912	-70 Reduced 2.55%	2,671 $1.03 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $6,495 - $11,749	-50 Reduced 1.79%	2,741 $644,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $65,508 - $111,588	-600 Reduced 17.69%	2,791 $365,000
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $222,924 - $575,995	3,391 New	3,391 $354,000

Others Institutions Holding MRNA

# of Institutions

1,112

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $26.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account